- Small Business Health Insurance | Sana Benefits
Flexible, affordable coverage with built-in primary care—made for small and midsize businesses that want great benefits without the hassle So much more than just a health plan Sana combines nationwide health coverage with Sana Care—our virtual-first primary care and care navigation service
- Sana (singer) - Wikipedia
Sana Minatozaki (Japanese: 湊﨑 紗夏; [1] born December 29, 1996), known mononymously as Sana (Korean: 사나; Japanese: サナ), is a Japanese singer based in South Korea She is a member of the South Korean girl group Twice, formed in 2015 by JYP Entertainment, and its subunit MiSaMo, formed in 2023
- Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to . . .
Sana Biotechnology’s share price has had a dramatic ride lately, climbing nearly 7% in just one day and soaring over 160% year-to-date, even against the backdrop of a recent pullback and a 1
- Sana Biotechnology to Present at December 2025 Investor Conferences
SEATTLE, Nov 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in December
- Sana (SANA) Surges 14. 5% Ahead of Business Announcements - MSN
Sana Biotechnology soared by 14 53 percent on Wednesday to finish at $4 02 apiece as investors loaded portfolios ahead of its business updates next week
- Sana Biotechnology (NASDAQ:SANA) Trading 12. 8% Higher - MarketBeat
Sana Biotechnology, Inc (NASDAQ:SANA - Get Free Report)'s share price traded up 12 8% on Wednesday The company traded as high as $3 72 and last traded at $3 9610 2,267,224 shares traded hands during trading, a decline of 59% from the average session volume of 5,570,718 shares The stock had previously closed at $3 51
- Members – Sana Benefits
Resources to help Sana members understand their benefits and how to use our website
- Sana Biotechnology cuts the ribbon at new manufacturing . . . - GeekWire
Sana has developed a proprietary gene-editing mechanism that blinds a person’s immune system to engineered therapeutic cells, which it would attack in normal circumstances
|